(Q37022851)
Statements
Comparison of once- versus twice-daily administration of insulin detemir, used with mealtime insulin aspart, in basal-bolus therapy for type 1 diabetes: assessment of detemir administration in a progressive treat-to-target trial (ADAPT) (English)
Jean-Pierre Le Floch
Marc Lévy
Helen Mosnier-Pudar
Frank Nobels
Sylvie Laroche
Sophie Gonbert
Eveline Eschwege
Assessment of Detemir Administration in Progressive Treat-to-Target Trial (ADAPT) Study Group
22 October 2008
1 reference
1 reference
1 reference
1 reference